Morphine Sulfate Injection USP, Simplist® 2 mg/1 mL
Product details
- Morphine Sulfate Injection USP, Simplist® 2 mg/1 mL
Company announcement
Fresenius Kabi is voluntarily recalling one lot of Morphine Sulfate Injection USP, Simplist® 2 mg/1 mL nationwide.
The recall is due to a label mix-up where a MicroVault labeled as Morphine 2 mg/1 mL may contain a Prefilled Syringe of Dilaudid 0.5 mg/0.5 mL.
No adverse event reports, injuries, or deaths have been reported to date for this lot number.
Risk:
Use of a MicroVault labeled as Morphine Sulfate Injection 2 mg/mL containing a prefilled syringe of Dilaudid (hydromorphone HCl) 0.5 mg/0.5 mL has a reasonable probability of causing serious adverse health consequences, including life-threatening respiratory depression and death. Patients at greatest risk include individuals who do not use opioids on a regular basis, those with underlying respiratory disease, pediatric patients, and those who are also taking central nervous system (CNS) depressants.
Impacted states: Nationwide
Products:
- Morphine Sulfate Injection USP, Simplist® 2 mg / 1 mL, 1 mL fill in a single dose 1 mL Simplist® prefilled syringe (UPC code(s): 7604500401)
Contact
For more information, call 1-800-551-7176 or email productcomplaint.USA@fresenius-kabi.com.
Related recalls
- 0.9% Sodium Chloride Injection, USP, 500 mL VIAFLEX Plastic Container
- Anticoagulant Sodium Citrate Solution USP, 250 mL VIAFLEX Plastic Container
- 70% Dextrose Injection, USP in 2000 mL VIAFLEX Plastic Container
- Thyroid Tablets, USP 30 mg
- Glutathione Injection 200MG/ML (30ML), Multi-Dose Vial
- Excel® Lactated Ringers Injection, 1000mL